NCT00921830View on ClinicalTrials.gov

Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

November 30, 2004

Conditions
Healthy
Interventions
DRUG

ibuprofen

Each subject will receive single doses of (i) ibuprofen 50 mg suppository (ii) ibuprofen 200 mg suppository and (iii) ibuprofen 200 mg tablet in 3 separate dosing periods. Doses will be administered after an overnight fast.

Trial Locations (1)

Unknown

Shandon Clinic, Cork

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT00921830 - Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories | Biotech Hunter | Biotech Hunter